CLDI
Price
$1.50
Change
+$0.07 (+4.90%)
Updated
Dec 3 closing price
Capitalization
10.75M
Intraday BUY SELL Signals
ORYZF
Price
$3.36
Change
-$0.25 (-6.93%)
Updated
Nov 17 closing price
Capitalization
298.2M
Intraday BUY SELL Signals
Interact to see
Advertisement

CLDI vs ORYZF

Header iconCLDI vs ORYZF Comparison
Open Charts CLDI vs ORYZFBanner chart's image
Calidi Biotherapeutics
Price$1.50
Change+$0.07 (+4.90%)
Volume$101.99K
Capitalization10.75M
Oryzon Genomics SA
Price$3.36
Change-$0.25 (-6.93%)
Volume$145
Capitalization298.2M
CLDI vs ORYZF Comparison Chart in %
CLDI
Daily Signal:
Gain/Loss:
ORYZF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CLDI vs. ORYZF commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDI is a Hold and ORYZF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (CLDI: $1.43 vs. ORYZF: $3.36)
Brand notoriety: CLDI and ORYZF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDI: 12% vs. ORYZF: 20%
Market capitalization -- CLDI: $10.61M vs. ORYZF: $298.2M
CLDI [@Biotechnology] is valued at $10.61M. ORYZF’s [@Biotechnology] market capitalization is $298.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDI’s FA Score shows that 0 FA rating(s) are green whileORYZF’s FA Score has 1 green FA rating(s).

  • CLDI’s FA Score: 0 green, 5 red.
  • ORYZF’s FA Score: 1 green, 4 red.
According to our system of comparison, CLDI is a better buy in the long-term than ORYZF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDI’s TA Score shows that 2 TA indicator(s) are bullish while ORYZF’s TA Score has 1 bullish TA indicator(s).

  • CLDI’s TA Score: 2 bullish, 5 bearish.
  • ORYZF’s TA Score: 1 bullish, 3 bearish.
According to our system of comparison, ORYZF is a better buy in the short-term than CLDI.

Price Growth

CLDI (@Biotechnology) experienced а +2.14% price change this week, while ORYZF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORYZF($298M) has a higher market cap than CLDI($10.8M). ORYZF YTD gains are higher at: 107.407 vs. CLDI (-89.638). ORYZF has higher annual earnings (EBITDA): -4.35M vs. CLDI (-17.92M). ORYZF has more cash in the bank: 31.1M vs. CLDI (5.28M). CLDI has less debt than ORYZF: CLDI (4.01M) vs ORYZF (13.7M). CLDI (0) and ORYZF (0) have equivalent revenues.
CLDIORYZFCLDI / ORYZF
Capitalization10.8M298M4%
EBITDA-17.92M-4.35M412%
Gain YTD-89.638107.407-83%
P/E Ratio4.17N/A-
Revenue00-
Total Cash5.28M31.1M17%
Total Debt4.01M13.7M29%
TECHNICAL ANALYSIS
Technical Analysis
CLDIORYZF
RSI
ODDS (%)
N/A
Bullish Trend 6 days ago
40%
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
Bearish Trend 6 days ago
64%
Bearish Trend 6 days ago
19%
MACD
ODDS (%)
Bullish Trend 6 days ago
42%
N/A
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
41%
Bullish Trend 6 days ago
20%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 6 days ago
8%
Advances
ODDS (%)
Bullish Trend 6 days ago
52%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
37%
N/A
Aroon
ODDS (%)
Bearish Trend 6 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CLDI
Daily Signal:
Gain/Loss:
ORYZF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CMALX26.83N/A
N/A
Crawford Multi-Asset Income
VCKSX9.92N/A
N/A
Virtus KAR Small-Mid Cap Growth C
GEQYX67.71N/A
N/A
GuideStone Funds Equity Index Instl
JCVWX25.43N/A
N/A
JHancock Classic Value R6
GLPSX38.17N/A
N/A
Goldman Sachs MLP Energy Infras R6

CLDI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDI has been loosely correlated with RYTM. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDI jumps, then RYTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDI
1D Price
Change %
CLDI100%
-3.38%
RYTM - CLDI
37%
Loosely correlated
-3.50%
ORYZF - CLDI
37%
Loosely correlated
N/A
CRNX - CLDI
33%
Poorly correlated
-0.53%
PROK - CLDI
32%
Poorly correlated
N/A
CLDX - CLDI
32%
Poorly correlated
+2.85%
More

ORYZF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORYZF has been loosely correlated with CLDI. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ORYZF jumps, then CLDI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORYZF
1D Price
Change %
ORYZF100%
N/A
CLDI - ORYZF
37%
Loosely correlated
-3.38%
PPBT - ORYZF
28%
Poorly correlated
-7.51%
DRUG - ORYZF
25%
Poorly correlated
+0.68%
GNNSF - ORYZF
24%
Poorly correlated
N/A
IPSC - ORYZF
20%
Poorly correlated
-2.62%
More